
Invivyd Inc (IVVD) Stock Forecast & Price Target
Invivyd Inc (IVVD) Analyst Ratings
Bulls say
Invivyd is in a strong position due to their successful development of antibodies for COVID-19 and their ongoing research on other viral diseases. The company's lead product, PEMGARDA, has already received emergency use authorization from the FDA and the potential approval of VYD2311 for COVID-19 prevention is a major catalyst for future growth. The company's partnerships and collaborations also indicate a strong potential for future investments and market opportunities in the vaccine development space.
Bears say
Invivyd is well-positioned in the biopharmaceutical industry with effective anti-SARS-CoV-2 antibodies and promising next-generation candidates for other viral diseases. However, market challenges such as vaccine hesitancy, evolving variants, and complex commercial markets may impact the company's sales and growth potential. The success of its future developments and ability to navigate these challenges will be critical in determining its long-term success.
This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.
Invivyd Inc (IVVD) Analyst Forecast & Price Prediction
Start investing in Invivyd Inc (IVVD)
Order type
Buy in
Order amount
Est. shares
0 shares